Schiff gets 2nd takeover offer

Share this article:

Consumer goods firm Reckitt Benckiser commenced a tender offer for vitamin and supplement company Schiff valued at $200 million more than an acquisition deal Schiff already signed with Bayer HealthCare.

Reckitt's bid for Schiff came in at $42.00 per share in cash, valuing Schiff at $1.4 billion—a 23.5% premium over Bayer's bid.

On October 30, Schiff signed a deal to be acquired by Bayer Healthcare in a transaction valued at $1.2 billion.

Schiff markets OTC brands Omega 3 supplement MegaRed and Airborne immune system health supplement, as well as nutrition bars and vitamins.
Share this article:
You must be a registered member of MMM to post a comment.
close

Next Article in Features

Email Newsletters

More in Features

Read the complete September 2014 Digital Edition

Read the complete September 2014 Digital Edition

Click the above link to access the complete Digital Edition of the August 2014 issue of MM&M, with all text, charts and pictures.

Medical marketing needs mainstream Mad Men

Medical marketing needs mainstream Mad Men

Agencies must generate emotional resonance with the target audience, not unlike Apple, Pepsi or Nike

Are discounts cutting out co-pays?

GSK's decision to cut Advair's price spurred some PBMs to put it back on formulary. Will drugmaker discounts diminish the need for loyalty programs? How can these programs stay relevant beyond giving co-pay assistance?